Evaluation of Bacillus anthracis thymidine kinase as a potential target for the development of antibacterial nucleoside analogs

Biological Chemistry

Volumn 387, Issue 12, 2006, Pages 1575-1581

  Carnrot, Cecilia ^a   Vogel, Susan R ^b   Byun, Youngjoo ^b   Wang, Liya ^a   Tjarks, Werner ^b   Eriksson, Staffan ^a   Phipps, Andrew J ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

5 fluoro deoxyuridine; Characterization; Growth inhibition; Kinetics; Thymidine

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ADENOSINE TRIPHOSPHATE; ANTHRAX VACCINE; BROXURIDINE; CLADRIBINE; CYTARABINE; DEOXYURIDINE DERIVATIVE; FLUOROURACIL; FLUOROURIDINE; GANCICLOVIR; HYDROXYUREA; MERCAPTOPURINE; NUCLEOSIDE DERIVATIVE; STAVUDINE; THYMIDINE; THYMIDINE KINASE;

ANIMAL CELL; ANTHRAX; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; DIMERIZATION; ENZYME ANALYSIS; ESCHERICHIA COLI; EVALUATION; GEL PERMEATION CHROMATOGRAPHY; GENE EXPRESSION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; DRUG DESIGN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NUCLEOSIDES; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; THYMIDINE KINASE;

BACILLUS ANTHRACIS;

EID: 33751520341     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.196     Document Type: Article

References (27)

1. Al-Madhoun, A., Tjarks, W., and Eriksson, S. (2004). The role of thymidine kinase in the activation of pyrimidine nucleoside analogues. Mini Rev. Med. Chem. 4, 341-350.
2. Auerbach, S. and Wright, G. (1955). Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis. J. Immunol. 75, 129-133.
3. Balzarini, J., Herdewijn, P., and De Clercq, E. (1989). Differential patterns of intracellular metabolism of 2′,3′-didehydro2′, 3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potential anti-human immunodeficiency virus compounds. J. Biol. Chem. 264, 6127-6133.
4. Bandyopadhyaya, A., Johnsamuel, J., Al-Madhoun, A., Eriksson, S., and Tjarks, W. (2005). Comparative molecular field analysis and comparative molecular similarity indices analysis of human thymidine kinase 1 substrates. Bioorg. Med. Chem. 13, 1681-1689.
5. Black, M. and Hruby, D. (1990). Identification of the ATP-binding domain of vaccinia virus thymidine kinase. J. Biol. Chem. 265, 17584-17592.
6. Blondin, C., Serina, L., Wiesmuller, L., Gilles, A., and Barzu, O. (1994). Improved spectrophotometric assay of nucleoside monophosphate kinase activity using the pyruvate kinase/lactate dehydrogenase coupling system. Anal. Biochem. 220, 219-221.
7. Brook, I., Elliott, T., Pryor, H.N., Sautter, T., Gnade, B., Thakar, J., and Knudson, G. (2001). In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int. J. Antimicrob. Agents 18, 559-562.
8. Carnrot, C., Wehelie, R., Eriksson, S., Bölske, G., and Wang, L. (2003). Molecular characterization of thymidine kinase from Ureaplasma urealyticum: nucleoside analogues as potent inhibitors of mycoplasma growth. Mol. Microbiol. 50, 771-780.
9. Cole, L. (1996). The specter of biological weapons. Sci. Am. 275, 60-65.
10. Dawson, L. and Lawrence, T. (2004). The role of radiotherapy in the treatment of liver metastases. Cancer J. 10, 139-144.
11. Eriksson, S., Munch-Petersen, B., Johansson, K., and Eklund, H. (2002). Structure and function of cellular deoxyribonucleoside kinases. Cell. Mol. Life Sci. 59, 1327-1346.
12. Friedlander, A. (2000). Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr. Clin. Top. Infect. Dis. 20, 335-349.
13. Friedlander, A., Welkos, S., Pitt, M., Ezzell, J., Worsham, P., Rose, K., Ivins, B., Lowe, J., Howe, G., Mikesell, P., et al. (1993). Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167, 1239-1243.
14. Furman, P., Fyfe, J., St Clair, M., Weinhold, K., Rideout, J., Freeman, G., Nusinoff Lehrmann, S., Bolognesi, D., Broder, S., et al. (1986). Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83, 8333-8337.
15. Henderson, D., Peacock, S., and Belton, F. (1956). Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J. Hyg. 54, 28-36.
16. Inglesby, T., Henderson, D., Bartlett, J., Ascher, M., Eitzen, E., Friedlander, A., Hauer, J., McDade, J., Osterholm, M., O'Toole, T., et al. (1999). Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. J. Am. Med. Assoc. 281, 1735-1745.
17. Jernigan, J. (2001). Clinical trials report. Curr. Infect. Dis. Rep. 3, 505-511.
18. Johansson, N. and Eriksson, S. (1996). Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases. Acta Biochim. Pol. 43, 143-160.
19. Kosinska, U., Carnrot, C., Eriksson, S., Wang, L., and Eklund, H. (2005). Structure of the substrate complex of thymidine kinase from Ureaplasma urealyticum and investigations of possible drug targets for the enzyme. FEBS J. 272, 6365-6372.
20. Lunato, A., Wang, J., Woollard, J., Anisuzzaman, A., Ji, W., Rong, F., Ikeda, S., Soloway, A., Eriksson, S., Ives, D., et al. (1999). Synthesis of 5-(carboranylalkylmercapto)-2′-deoxyuridines and 3-(carboranylalkyl) thymidines and their evaluation as substrates for human thymidine kinases 1 and 2. J. Med. Chem. 42, 3378-3389.
21. Machover, D. (1991). Developments of the fluoropyrimidines as inhibitors of thymidylate synthase: pharmacologic and clinical aspects. J. Surg. Oncol. Suppl. 2, 42-50.
22. Marsh, S. and McLeod, H. (2001). Thymidylate synthase pharmacogenetics in colorectal cancer. Clin. Colorectal Cancer 1, 175-178.
23. Munch-Petersen, B., Tyrsted, G., and Cloos, L. (1993). Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties. J. Biol. Chem. 268, 15621-15625.
24. Okazaki, R. and Kornberg, A. (1964). Deoxythymidine kinase of Escherichia coli. II. Kinetics and feedback control. J. Biol. Chem. 239, 269-274.
25. Sambrook, J. and Russell, D.W. (2001). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press).
26. Sandrini, M. and Piskur, J. (2005). Deoxyribonucleoside kinases: two enzyme families catalyze the same reaction. Trends Biochem. Sci. 30, 225-228.
27. Welin, M., Kosinska, U., Mikkelsen, N.-E., Carnrot, C., Zhu, C., Wang, L., Eriksson, S., Munch-Petersen, B., and Eklund, H. (2004). Structures of thymidine kinase 1 of human and mycoplasmic origin. Proc. Natl. Acad. Sci. USA 101, 17970-17975.